JPS474164U - - Google Patents

Info

Publication number
JPS474164U
JPS474164U JP247171U JP247171U JPS474164U JP S474164 U JPS474164 U JP S474164U JP 247171 U JP247171 U JP 247171U JP 247171 U JP247171 U JP 247171U JP S474164 U JPS474164 U JP S474164U
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP247171U
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP247171U priority Critical patent/JPS474164U/ja
Publication of JPS474164U publication Critical patent/JPS474164U/ja
Pending legal-status Critical Current

Links

Landscapes

  • Packages (AREA)
  • Closures For Containers (AREA)
JP247171U 1971-01-23 1971-01-23 Pending JPS474164U (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP247171U JPS474164U (de) 1971-01-23 1971-01-23

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP247171U JPS474164U (de) 1971-01-23 1971-01-23

Publications (1)

Publication Number Publication Date
JPS474164U true JPS474164U (de) 1972-09-08

Family

ID=33428380

Family Applications (1)

Application Number Title Priority Date Filing Date
JP247171U Pending JPS474164U (de) 1971-01-23 1971-01-23

Country Status (1)

Country Link
JP (1) JPS474164U (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2098230A1 (de) 1997-03-31 2009-09-09 Boston Scientific Scimed Limited Verwendung von Cytoskelettinhibitoren in kristalliner Form zur Hemmung oder Vorbeugung der Restenose

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2098230A1 (de) 1997-03-31 2009-09-09 Boston Scientific Scimed Limited Verwendung von Cytoskelettinhibitoren in kristalliner Form zur Hemmung oder Vorbeugung der Restenose

Similar Documents

Publication Publication Date Title
ATA136472A (de)
AU2691671A (de)
AU2894671A (de)
AU3005371A (de)
AU2952271A (de)
AU2941471A (de)
JPS474164U (de)
AU2726271A (de)
AU2742671A (de)
AU2875571A (de)
AU2907471A (de)
AU2837671A (de)
AU2755871A (de)
AU2854371A (de)
AU2963771A (de)
AU2885171A (de)
AU2740271A (de)
AU2724971A (de)
AU2836771A (de)
AU2927871A (de)
AU2930871A (de)
AU2938071A (de)
AU2940971A (de)
AU2706571A (de)
AU2684171A (de)